S. M. KABAN, Siti Syarifah, Y. S. Pane, and Tri Widyawati, “The Relationship between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy”, JETROMI, vol. 7, no. 1, pp. 27–33, Feb. 2025.